Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib in Neuropathic Pain (PHN)
NCT01264237Phase 4Unknown
- Sponsor
- Analgesic Solutions
- Start
- Mar 2011
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postherpetic neuralgia (PHN) comparing Etoricoxib Arm with Placebo Arm (2 arms). Primary endpoint: Time to Efficacy Failure at 28 Days. Status: unknown.
02
Drugs
etoricoxib
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT01264237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01264237.